Houston Healthcare is putting patient safety first by offering low dose computed tomography (CT) exams with the industry’s best solutions and a comprehensive dose management approach from Toshiba America Medical Systems Inc. 

iRhythm Technologies Inc., a healthcare information services company, announced that new study data support the use of its ZIO Service to help identify underlying cardiac arrhythmias in patients who have had a stroke or transient ischemic attack (TIA). 

The U.S. Food and Drug Administration (FDA) cleared Toshiba’s CT Myocardial Perfusion capability. Available on Toshiba’s Aquilion One and Aquilion OneVison Edition CT systems, Myocardial Perfusion allows clinicians to visualize myocardial ischemia with CT, providing a clinical and operational solution to make work flow.

McKesson announced a cardiology solution called Qualitative Intelligence and Communication System (QICS). QICS for cardiology helps organizations automate and manage cardiology workflows to promote efficiency and effectiveness. The solution offers integrated workflows and results communications management within the cardiovascular information system (CVIS).

Corindus CorPath Robotic Navigation Telemedicine Telecardiology Cath Lab

For patients living in rural areas, life-saving procedures such as an angioplasty may only be available at a facility more than 200 miles away. To bridge this distance, Corindus Vascular Robotics is partnering with Sanford Health and The Leona M. and Harry B. Helmsley Charitable Trust to launch a feasibility study for a remote robotic systems cath lab telecardiology program. 

Countries across the globe are struggling to combat issues such as escalating healthcare costs, poor or inconsistent quality of healthcare, rapid expansion in healthcare insurance and changing healthcare reform mandates. Growing consumerism, globalization, changing demographics and lifestyles, and growing incidences of diseases that are expensive to treat further exacerbate these. Resolving these issues is a daunting task faced by healthcare stakeholders, highlighting the need for proactive, collaborative and systemic models. Several initiatives and healthcare reforms have been developed in order to support the adoption and implementation of clinical decision support software (CDSS) solutions.

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray

Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in X-ray medical examinations. FlowSens received CE marking in the first quarter of 2014. It will initially be marketed in Europe (first in Belgium, France, Germany and Switzerland), then gradually in other regions of the world.

Marty Greenfield lives with crushing pain every day due to angina. He has suffered a heart attack, and a coronary bypass procedure and angioplasty have provided little relief. His doctor referred him to University of California, Los Angeles to be considered for a heart transplant.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now